Responsibilities:

• Global responsibility for medical oversight of selected products, e.g. Ig or Albumin within the assigned disease area(s).

• Contributing to the medical affairs strategy for assigned portfolio in alignment with overall therapeutic area objectives

• Identifies potential challenges, risks and roadblocks associated with the global medical strategy and works as a leader in developing solutions to address these, working cross-functionally and inter functionally with other departments.

• Evaluates trends and therapeutic opportunities in cooperation with research and regional commercial and medical organizations

• Implements strategy for scientific interactions with the medical community including key opinion leaders and patient advocacy groups

• Supports coordination of investigator led studies and research collaborations

• Serves as scientific consultant to marketing, commercial, access and research project teams, providing input into promotional and educational materials for relevant therapeutic areas

• Ensures medical standards and processes are in alignment with expectations of manufacturers by internal and external stakeholders including regulators, governmental agencies, payors, physicians, patients and the general public.

Qualifications:

• Advanced degree in science (PhD, PharmD), MD or equivalent plus accredited residency.

• Minimum 8 years' relevant pharmaceutical/ biotherapeutics industry experience

• Sound experience interacting with commercial functions within the healthcare industry

• Knowledge of therapeutic specialty area, e.g. PID, SID or IgG-mediated autoimmune-diseases
• Experience and success in addressing and managing complex medical issues in the pre-approval and post-approval environment.

Different qualifications or responsibilities may apply based on local legal and/or educational requirements. Refer to local job documentation where applicable.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.

Our Benefits

For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.

You Belong at CSL

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.

To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging

Equal Opportunity Employer

CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.